{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:57:22Z","timestamp":1771991842847,"version":"3.50.1"},"reference-count":16,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>\n            Azithromycin is a component of empirical treatment regimens for\n            <jats:named-content content-type=\"genus-species\">Neisseria gonorrhoeae<\/jats:named-content>\n            infections, but antimicrobial susceptibility testing for this agent is technically challenging. We compared the intertest variability, MIC values, and CLSI\/EUCAST categorization of clinical and reference isolates of\n            <jats:named-content content-type=\"genus-species\">N. gonorrhoeae<\/jats:named-content>\n            treated with azithromycin by testing 107 clinical isolates and nine reference isolates by agar dilution and in duplicates using MIC test strips (Liofilchem, Italy) and Etests (bioM\u00e9rieux, France).\n          <\/jats:p>","DOI":"10.1128\/jcm.01353-19","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T11:27:55Z","timestamp":1570102075000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Variability in Azithromycin Susceptibility Results for Neisseria gonorrhoeae Obtained Using Gradient MIC Strip and Agar Dilution Techniques"],"prefix":"10.1128","volume":"57","author":[{"given":"Gary N.","family":"McAuliffe","sequence":"first","affiliation":[{"name":"Microbiology Department, LabPLUS, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Smith","sequence":"additional","affiliation":[{"name":"Microbiology Department, LabPLUS, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Cooper","sequence":"additional","affiliation":[{"name":"Microbiology Department, LabPLUS, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose F.","family":"Forster","sequence":"additional","affiliation":[{"name":"Auckland Regional Sexual Health Service, Greenlane Clinical Centre, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally A.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Microbiology Department, LabPLUS, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","volume-title":"Antimicrobial resistance: global report on surveillance, 2014","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. 2014. Antimicrobial resistance: global report on surveillance, 2014. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213312"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy551"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz292"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.04.016"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000651"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12887"},{"key":"e_1_3_1_9_2","first-page":"71","article-title":"Keeping track of antimicrobial resistance for Neisseria gonorrhoeae in Auckland, New Zealand: past, present and future considerations","volume":"131","author":"McAuliffe G","year":"2018","unstructured":"McAuliffe G, Smith M, Brokenshire M, Forster R, Reid M, Roberts S. 2018. Keeping track of antimicrobial resistance for Neisseria gonorrhoeae in Auckland, New Zealand: past, present and future considerations. N Z Med J 131:71\u201377.","journal-title":"N Z Med J"},{"key":"e_1_3_1_10_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2015. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0 2015. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_5.0_Breakpoint_Table_01.pdf."},{"key":"e_1_3_1_11_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 11th ed. Document M07-A10. Clinical Laboratory and Standards Institute, Wayne, PA.","edition":"11"},{"key":"e_1_3_1_12_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical Laboratory and Standards Institute","year":"2019","unstructured":"Clinical Laboratory and Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing, 29th ed. Document M100-29. Clinical Laboratory and Standards Institute, Wayne, PA.","edition":"29"},{"key":"e_1_3_1_13_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2019. Breakpoint tables for interpretation of MICs and zone diameters version 9.0 2019. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_9.0_Breakpoint_Tables.pdf."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx405"},{"key":"e_1_3_1_15_2","volume-title":"Sexually transmitted diseases treatment guidelines","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. 2015. Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention, Atlanta, GA."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2013.10.007"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw288"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01353-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01353-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:59:41Z","timestamp":1646470781000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.01353-19"}},"subtitle":[],"editor":[{"given":"Erik","family":"Munson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1128\/JCM.01353-19"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01353-19","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2019-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01353-19"}}